 |
 |


The 1982 Revised Criteria for Classification of Systemic Lupus Erythematosus
|
Criterion
|
Definition
|
| 1. Malar
rash |
Fixed
erythema, flat or raised, over the malar eminences, tending to spare the
nasolabial folds
|
| 2. Discoid
rash |
Erythematous
raised patches with adherent keratotic scaling and follicular plugging;
atrophic scarring may occur in older lesions
|
| 3. Photosensitivity |
Skin rash
as a result of unusual reaction to sunlight, by patient history or physician
observation
|
| 4. Oral
ulcers |
Oral or
nasopharyngeal ulceration, usually painless, observed by physician
|
| 5. Arthritis |
Nonerosive
arthritis involving 2 or more peripheral joints, characterized by tenderness,
swelling, or effusion
|
| 6. Serositis |
- a) Pleuritis--convincing
history of pleuritic pain or rubbing heard by a physician or evidence
of pleural effusion
- OR
- b) Pericarditis--documented
by ECG or rub or evidence of pericardial effusion
|
| 7. Renal
disorder |
- a) Persistent
proteinuria greater than 0.5 grams per day or grater than 3+ if quantitation
not performed
- OR
- b) Cellular casts--may
be red cell, hemoglobin, granular, tubular, or mixed
|
| 8. Neurologic
disorder |
- a) Seizures--in
the absence of offending drugs or known metabolic derangements; e.g.,
uremia, ketoacidosis, or electrolyte imbalance
- OR
- b) Psychosis--in
the absence of offending drugs or known metabolic derangements, e.g.,
uremia, ketoacidosis, or electrolyte imbalance
|
| 9. Hematologic
disorder |
- a) Hemolytic anemia--with
reticulocytosis
- OR
- b) Leukopenia--less
than 4,000/mm<>3<> total on 2 or more occasions
- OR
- c) Lyphopenia--less
than 1,500/mm<>3<> on 2 or more occasions
- OR
- d) Thrombocytopenia--less
than 100,000/mm<>3<> in the absence of offending drugs
|
| 10. Immunologic
disorder |
- a) Positive LE
cell preparation
- OR
- b) Anti-DNA: antibody
to native DNA in abnormal titer
- OR
- c) Anti-Sm: presence
of antibody to Sm nuclear antigen
- OR
- d) False positive
serologic test for syphilis known to be positive for at least 6 months
and confirmed by Treponema pallidum immobilization or fluorescent
treponemal antibody absorption test
|
| 11. Antinuclear
antibody |
An abnormal
titer of antinuclear antibody by immunofluorescence or an equivalent assay
at any point in time and in the absence of drugs known to be associated
with "drug-induced lupus" syndrome |
* The
proposed classification is based on 11 criteria. For the purpose of identifying
patients in clinical studies, a person shall be said to have systemic lupus
erythematosus if any 4 or more of the 11 criteria are present, serially or simultaneously,
during any interval of observation.
Tan EM, Cohen AS, Fries
JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for
the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271---7.
|
|
|